National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

News & Events
 News Releases
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
  1998
  1997
  1996
  1995
  By Topic
 Qs & As
 Media Inquiries
 Events & Calendars
 NIAID in the News
 Resources


 

Anopheles gambiae Genome Sequencing Project


March 5, 2001 


Statement of Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases


Today, a global network of researchers announced that they are collaborating in sequencing the genome of Anopheles gambiae, the mosquito responsible for most cases of malaria in Africa. The National Institute of Allergy and Infectious Diseases (NIAID) applauds the efforts of the network and their goal of obtaining sequence data by the end of the year.

This information, together with the knowledge gained from the sequences of malaria parasites and the human genome, will provide researchers with a wealth of genomic data necessary for understanding this complex disease. (See the communique.)

The need for a multifaceted commitment to fight malaria and develop new and improved treatments, diagnostics and vaccines has never been greater. According to the World Health Organization, an estimated 300 to 500 million cases of malaria occur annually; in 1999, an estimated 1.1 million deaths were attributed to malaria, most of which occurred in children under the age of 5. Malaria is a public health threat in more than 90 countries, where 40 percent of the world's population lives. Because of the enormity of this problem, NIAID has made malaria research a central focus of our scientific portfolio and supports a comprehensive research program, which includes basic, field-based and clinical research.

Malaria is caused by a single-celled parasite that is spread to humans by mosquitoes. The control of malaria continues to be a challenge because of the dual problems of increased rates of insecticide resistance in mosquitoes and increased rates of drug resistance in the malaria parasites. Reducing disease transmission by mosquito control has been a mainstay of regional and global malaria control programs. The insecticide DDT was once a powerful tool in global efforts to eradicate malaria. With the development of DDT-resistant mosquitoes, new tools are needed to control this disease. An improved understanding of the basic biology of mosquitoes and their genomes will contribute to our ability to understand and monitor insecticide resistance, develop new insecticides, and ultimately help control the malaria pandemic.

back to top


 

E-mail update Receive notifications by e-mail when NIAID press releases update.

NIAID is on Twitter

twitter logo
Get a tweet the moment NIAID posts a news release.

See Also

  • Media Contact Info
  • News Releases by Topic
  • Health & Research Topics

  •  

    E-mail update Receive notifications by e-mail when NIAID press releases update.

    NIAID is on Twitter

    twitter logo
    Get a tweet the moment NIAID posts a news release.

    See Also

  • Media Contact Info
  • News Releases by Topic
  • Health & Research Topics